Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database

por Scheid, Christof, Blau, Igor W., Sellner, Leopold, Ratsch, Boris A., Basic, Edin
Publicado 2020

Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany

por Basic, Edin, Kappel, Mathias, Misra, Arpit, Sellner, Leopold, Ratsch, Boris A., Ostwald, Dennis A.
Publicado 2020

Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

por Wilke, Thomas, Mueller, Sabrina, Bauer, Sabine, Pitura, Silvia, Probst, Leona, Ratsch, Boris A, Salwender, Hans
Publicado 2018

Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman

por Al Baqlani, Said Ali, Sy, Bui Tien, Ratsch, Boris A., Al Naamani, Khalid, Al Awaidy, Salah, Busaidy, Suleiman Al, Pauli, Georg, Bock, C.-Thomas
Publicado 2014

High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naïve HBsAg-Positive Patients in Northern Vietnam

por Sy, Bui Tien, Ratsch, Boris A., Toan, Nguyen Linh, Song, Le Huu, Wollboldt, Christian, Bryniok, Agnes, Nguyen, Hung Minh, Luong, Hoang Van, Velavan, Thirumalaisamy P., Wedemeyer, Heiner, Kremsner, Peter G., Bock, C.-Thomas
Publicado 2013